Background: Dyslipidemia is a major risk factor for cardiovascular disease. Lipid lowering drugs are available in modern medicine but prolong use of these drugs may produce some side effects. Peanut due to some of its active component can improve lipid profile. Objective: To observe the effects of peanut (Arachis hypogaea L.) on dyslipidemia in young adults. Methods: This prospective interventional study was carried out in the Department of Physiology, Sir Salimullah Medical College (SSMC), Dhaka between 1 st July 2013 and 30 th June 2014. For this purpose 30 dyslipidemic young adults of both sexes with aged 30 to 40 years were included in this study and they were selected from Out Patient Department of Medicine of Sir Salimullah Medical College and Mitford Hospital, Dhaka. They were studied three times i,e before supplementation with peanut (BSP), after 4 weeks supplementation with peanut (4 wks AP) and after 8 weeks supplementation with peanut (8 wks AP). For assessing lipid profile TAG, LDL-C, TC and HDL-C of all subjects were estimated by enzymatic method. The statistical analysis was done by using paired sample't' test as applicable. Results: In this study, the mean serum TAG, LDL-C and TC levels were significantly decreased after 8 weeks supplementation with peanut in comparison to those of after 4 weeks and before supplementation with peanut. However, these levels were also decreased after 4 weeks supplementation than those of before supplementation but it was significant only for TC (p<0.05) and LDL-C (p<0.001). Whereas, the mean serum HDL-C level was significantly (p<0.001) increased after 8 weeks supplementation when compared to those of after 4 weeks and before supplementation of peanut. Conclusion: The present study revealed that, peanut (Arachis hypogaea L.) has effect on improvement of lipid profile by lowering serum TAG, LDL-C, TC levels and by increasing serum HDL-C level. This lipid lowering effects of peanut may be due to its high Mg +2 content and other active components of peanut.
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Accepted November 2014 yslipidemia is a disorder of lipoprotein metabolism, which includes increase blood concentrations of total development of cardiovascular diseases (CVD) 1 . Cardiovascular disease (CVD) includes hypertension, coronary heart disease, angina, myocardial infarction, heart failure etc 2 . According to World Health Organization (WHO), about 17.5 million people died from CVDs in 2005, representing 30% of global deaths and over 80% deaths take place in low and middle socio-economic countries
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like Bangladesh 3 . Due to rapid urbanization the coronary heart disease in middle aged and young group is appearing at increasing level in Bangladesh 4 . However, recently a study showed a significant relationship of dyslipidemia with age, sedentary occupation, body mass index (BMI), diet and smoking among some young adult Bangladeshi subjects aged 18 and above 5 . Again, dyslipidemia and obesity two important risk factors of CVDs were found in some employers of Bangladesh secretariat who had sedentary life style 6 . Another study in Bangladesh revealed that 27.93%, 21.08% and 13.41% stroke patients with lipid disorder had high cholesterol, low density lipoprotein (LDL), and triglyceride (TG) levels respectively and 42.67% patients had low HDL level. Furthermore, the levels of serum TC, LDL-C and TG were found higher among some educated and high income urban population of Rajshahi city 7 .
Arachis hypogaea L. known as peanut belongs to the family of fabaceae has been valued for its high nutritional content throughout the world for many years 8 . Peanut is a nutrient dense food rich in plant protein (10%-25%) and fat (50%-75%) 9 . Peanut is rich in unsaturated fatty acid predominantly monounsaturated fatty acid (MUFA) and polyunsaturated fatty acids (PUFA) and low saturated fatty acids and also contain several non-fat bioactive constituents such as plant protein 10 , dietary fiber 11 , non-starch polysaccharides 12 , arginine 13 , vitamins (e.g., folic acid, niacin, tocopherol and pyridoxine), minerals (e.g., magnesium, copper, calcium and potassium) and many other bioactive constituents such as phytosterols 14 , flavonoids and resveratrol 13 . However, peanut causes food allergy approximately 1% in general population 15 and mainly affects young children 16 . It has been observed that, consuming two ounce of nuts daily as replacement for carbohydrates can reduce blood glucose and LDL-C levels in people with diabetes 17 . Some other researchers showed that, daily 56 g peanut consumption may improve blood HDL-cholesterol levels 18 .
Due to some active components peanut has highly medicinal value and it is cultivated in many places of Bangladesh such as Kurigram, Rangpur, Mymensingh, Joydebpur etc. It is relatively cheap and available in relation to other nuts. Therefore, the present study has been designed to observe the effect of peanut on dyslipidemia in young adults. It is also expected that the result of this study would make peanut accectable among the people as a rich source of nutrition with medicinal value for the prevention and treatment of dyslipidemia. Subjects having diabetes mellitus, hypertension, heart disease, kidney disease, liver disease, thyroid disease, infectious disease etc were excluded from the study. Informed written consent was taken from each subject. Subsequently, a detail family and medical histories were taken to rule out any chronic and known illness which runs in the family and also physical activity status were recorded. All the subjects were supplemented with peanut at about 20% of their daily calorie intake. Three days dietary history of each subjects was taken for calculating the amount of peanut that was supplemented to each of the subjects (Table 1) .
Methods
With all aseptic precautions, five (5) ml of venous blood was drawn from median cubital vein by sterile disposable syringe. To assess their lipid profile serum level of TAG, LDL-C, HDL-C and TC of all subjects were estimated by enzymatic method in the laboratory of Department of Physiology, Sir Salimullah Medical College, Dhaka. Data were analyzed by Paired sample 't' test as applicable for statistical analysis. P value < 0.05 was taken as level of significance.
Results
In this study, BMI was significantly decreased in 8 wks AP in comparison to that of BSP. Again, this level was almost similar in BSP and 4 wks AP bu the difference was not statistically significant.
The mean W:H ratio level was almost similar and the differences was not statistically significant after 4 weeks and 8 weeks supplementation of peanut (Table II) . In this study, serum level of TAG, LDL-C and TC were significantly decreased in 8 wks AP in comparison to those of 4 wks AP and BSP. Serum HDL-C level was significantly increased in 8 wks AP in comparison to that of 4 wks AP and BSP (Table III) . 
Discussion
In this study, serum level of TAG, LDL-C and TC were significantly decreased and serum HDL-C level was significantly increased in 8 wks AP in comparison to that of 4 wks AP and BSP. This finding is consistent with that of some other investigators 18, 19, 20 . In contrast, some other researchers did not find any significant change of serum TC and TAG levels in hypercholesterolemic subjects by dietary supplementation with peanut for 4 weeks This discrepancy may be due to their short duration of study period 18, 21 .
It has been suggested that circulating level of excess cholesterol causes development of atheroma within intima layer of the arterial wall. Ulceration or disruption of the atheroma causes thrombotic occlusion or embolism which impairs blood flow to vital organ such as brain, heart and other organs 2 . However, oleic acid which is the predominant mono-unsaturated fatty acid (MUFA) in peanut 22 , exerts anti-hypertensive effects 23 , prevents LDL oxidation 24 , reduces platelet aggregation 25 and enhances fibrinolysis, thereby reduces the risk of cardiovascular diseases 26, 27 .
The flavonoids and phytosterols in peanut can inhibit dietary cholesterol absorption thereby decreasing blood cholesterol levels 28, 29 . Again, Resveratrol, a polyphenol phytoalexin of peanuts provides protection from atherosclerosis by decreasing serum total cholesterol (TC) and triglyceride (TG) levels and increasing serum HDL level 30 . In addition, fiber of peanut reduces total and LDL-cholesterol level and reduces insulin resistance 12 . Nut is one of the best dietary sources of vitamin E (á-tocopherol) and is associated with reduced risk of coronary heart disease (CHD) by inhibition of LDL oxidation 10 .
Regular consumption in small amount of peanut contributes daily requirement for Mg +2 10 . Some studies confirm that, dietary Mg +2 decreases serum cholesterol and triglycerides levels 31 . Low serum Mg +2 concentrations can reduce lipoprotein lipase and lecithincholesterol acyltransferase (LCAT) activity which results in hyperlipidemia 32 .
In the present study, improvement of lipid profile is found in young adult as evidenced by gradual decreased levels of serum TC, LDL-C, TAG and gradual increased level of HDL-C after 4 weeks and 8 weeks supplementation of peanut. This lipid lowering effect of peanut may be due to its higher content of Mg +2 and other active component.
Conclusion
From this study, it can be concluded that, peanut (Arachis hypogoea L.) has got significant effect on improvement of lipid profile with lowering 
